newsfilter
← Latest News
Business Wire·

TriSalus Life Sciences Reports Second Quarter 2025 Results and Reiterates 2025 Guidance

Company delivers $11.2M in revenues resulting in 52% growth year-over-year and 22% growth quarter-over-quarter Broadened PEDD portfolio with launch of TriNav FLX designed to improve access in tortuous vessels Confirming